I highly recommend this conference. Last year it was one of the most informative and interesting conferences that I attended. 



Kingsmill Resort & Spa

Williamsburg, Virginia

May 17 – 19, 2009


Preliminary Agenda




With the likely advent of FDA/FCTC tobacco legislation and continually increasing economic and social pressure on the industry and its customers, not the least of which is the recent SCHIP tax increases in the US market, it is more important than ever to discuss issues impacting the state of the industry and what options the industry has to ensure compliance at least cost.  Given this situation, the conference will provide attendees with a global overview of the current state of the industry, with an added focus on the US market, what the likely future has to bring and how alternative actionable methods may be used by companies to address these challenges. 


The 2009 conference program agenda was designed based on survey responses from past attendees and focuses on issues identified as most important by this group.  As such, the program primarily concentrates on providing a marketplace overview with additional emphasis on the pending FDA legislation and likely ratification by the US of the Framework Convention on Tobacco Control (FCTC) and its implementing legislation.




Golf Outing: 10:00 AM – 3:00 PM

TMA Board Meeting: 4:00 PM – 6:00 PM

Welcome Reception: 6:30 PM – 9:00 PM




What Is


8:00 AM  Continental Breakfast


8:30 AM – 9:20 AM


1.     Welcome – Farrell Delman, TMA President

2.   Global Tobacco Leaf Trends – James H. Starkey, TMA Chairman

3.   Product/Market/Regulatory Trends and likely SCHIP Impacts – Farrell Delman


9:20 AM – 10:40 AM


4.     Security Analyst Panel –  Nik Modi (UBS), Adam Spielman (Citigroup), Erik Bloomquist (JP Morgan) and possibly David Hayes (Nomura), Anne Gurkin (Davenport) and Judy Hong (Goldman Sachs) – Moderator: Darryl Jayson, TMA Vice President


Review the historical, current and future projections for tobacco Industry manufacturers, wholesalers, retailer and suppliers.  How will the financial community incorporate the short and longer term implications of the US tax increases, the FDA legislation, the FCTC and the overall worsening global economy, in their forecasting and reporting for the US and other markets?


10:40 AM – 11:00 AM  Coffee Break


11:00 AM – 11:30 AM


            Introduction of Nick Simeonidis, Patton Boggs – Moderator for Remaining Program


5.     US/World Regulatory Overview: FCTC- FDA

Moderator: Adrian Payne, President Tobacco Horizons Inc.

o   A broad comparison of the FCTC with the proposed FDA legislation

o   Key issues (concerns) present in the FDA legislation

o   Global implications of US FDA legislation in terms of FCTC working groups & protocols

o   Additional concerns posed by the FCTC

o   What’s on the horizon?


11:30 AM – 12:15 PM


6.     Nicotine & Non-Nicotine Alternatives:  What’s Hot, What’s Not?

Moderator:  Pharma Representative and David O’Reilly, BAT, invited

o   Overview of this category of products

o   Legislation in progress related to these products

o   Evolution of this product category

o   Current Global Status of THR

o   New knowledge on the scientific front

o   Advances/declines from last year


12:30 PM – 2:00 PM  LUNCH


Keynote: “Tobacco Harm Reduction – Congressman Buyer vs. Congressman Waxman”  Speaker:  Congressman Stephen Buyer, invited


2:00 PM – 4:00 PM


7.   The Devil’s in the FDA Regulations – Nick Simeonidis, Moderator

o   Overview – Legal – John Manthei, Latham & Watkins

o   Dealing with FDA: the Pharma Experience – Uwe Trinks, Foresight Group

o   Impact on Manufacturing Practices – John Lauterbach, Lauterbach & Associates

o   Impact on Suppliers – Roger Penn, Mane France

o   Impact on Product Testing: The Canadian Experience – Bill Rickert, Labstat, invited

o   Impact on Product Development & Reporting – Jim Swauger – RAI, invited

o   Impact on Marketing and Sales – Bhavani Parameswar, President, KingMaker

o   Impact on Retail & Distribution – Terry Gallagher, CEO, Smoker Friendly, invited


4:00 PM – 6:30 PM  Free time


6:30 PM – 10:00 PM  TMA Annual Meeting and Dinner


6:30 PM – 7:30 PM  Cocktail Party

7:30 PM – 8:30 PM  Dinner

8:30 PM – 9:00 PM  Annual Meeting (dessert)

9:00 PM – 9:40 PM  Keynote Address:

     Kurush Grant, ITC Limited, Chief Executive Tobacco Division

       “India’s Experience Under the FCTC and an active Health Minister “




What Will and Could Be



8:00 AM  Continental Breakfast


8:30 AM – 8:50 AM 


8.   TMA’s Tobacco Product Compliance Center (TPCC): Update

                                    Darryl Jayson, TMA Vice President


8:50 AM – 9:10 AM


9.     What FDA/SCHIP Means for Adult Consumers


Adult tobacco product consumers are exposed to increasing prices, social pressures and the communication of tobacco related information by health care personnel and federal health agencies.  What can consumers expect in the future and what steps will the tobacco industry take to communicate with, and meet the wants of their consumers in a way that reasonable elements in tobacco control and the regulatory authorities condone.



9:00 AM – 9:30 AM


10. What FDA/SCHIP Means for Youth Smoking


Eliminating youth tobacco consumption in any form is a benchmark for the success of regulation.  FDA and SCHIP are both designed in part to discourage, even prevent, the initiation of youth tobacco use. How is youth involvement with tobacco currently being measured?  What do we know about how youth smoking has evolved over the past few decades? How will FDA regulation and higher prices due to SCHIP along with escalating State excise taxation further impact initiation? What is the likelihood that youth will migrate to alternative forms of tobacco?  In the best of all possible worlds, what sorts of messaging would government encourage to reduce health risks associated with youth tobacco consumption.  Lyle Smith, DLC Services, Inc., formerly RJRT



9:30 AM – 11:00 AM


  1.  Towards An FDA Industry Advisory Group – Moderator: John Lauterbach


Faced with the operational (manufacturing, marketing and reporting) restrictions, product limitations and reporting requirements resulting from FDA legislation, what should companies be doing now to prepare their organizations and their consumers to meet these hurdles?


11:00 AM


Q & A with Various Conference Speakers:  Uwe Trinks (Foresight Group), Roger Penn (Mane France), Nick Simeonidis (Patton Boggs) John Manthei (Latham Watkins), Lyle Smith (DLC Services) and additional panelists including Bryan Haynes (Troutman Sanders) and Bill Greiwe (Cheyenne Tobacco).




#1 ... on 03.10.09 at 9:28 AM

where can you find the regestration info for the conferance????

#2 TAZ on 03.25.09 at 6:28 PM

Copy and put in your browser for more information!

Leave a Comment